Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared a proud post on LinkedIn:
”Sex-related differences in platelet reactivity are emerging as a relevant factor in patients both on and off antiplatelet therapy.
In these two recent contributions, published almost simultaneously, we present evidence from both randomized controlled trials and the largest pharmacodynamic study in this setting to date, suggesting that females may benefit from antiplatelet regimens different from those typically used in males.
This represents another important step forward in advancing precision medicine in cardiology.”
Read the full articles in European Heart Journal and EHJ Cardiovascular Pharmacotherapy.
Article 1: Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Authors: Giovanni Occhipinti , Claudio Laudani , Mattia Galli , Luis Ortega-Paz , Vijay Kunadian , Guiomar Mendieta , Riccardo Rinaldi , Felicita Andreotti , Roxana Mehran , Teresa López-Sobrino , Davide Capodanno , Dominick J Angiolillo , Manel Sabaté Tenas , Salvatore Brugaletta
Article 2: Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy
Authors: Mattia Galli , Sergio Terracina , Eleonora Schiera , Simone De Corci , Diego Sangiorgi , Massimo Mancone , Luigi Frati , Sebastiano Sciarretta , Dominick J Angiolillo , Fabio M Pulcinelli
Stay updated on all science in the field of platelet disorders with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies